Go to Header Go to Navigation Go to Content Go to Footer
-
-
-
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial (2023)- European Journal of Cancer
Sabatier R, Rousseau F, Joly F, Cropet C, Montégut C, Frindte J, Cinieri S, Guerra Alía EM, Polterauer S, Yoshida H, Vergote I, Colombo N, Hietanen S, Largillier R, Canzler U, Gratet A, Marmé F, Favier L, Pujade-Lauraine E, Ray-Coquard I
-
An integrative review of the continuing professional development needs for nurse educators (2023)Smith J, Kean S, Vauhkonen A, Elonen I, Campos Silva S, Pajari J, Cassar M, Pajari J, Martin-Deldago L, Zrubcova D, Salminen L
-
-
-
-